Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 4,711
Out of 4,712 analysts
21
Total ratings
6.67%
Success rate
-47.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNOX Bionomics | Maintains: Buy | $10 → $17 | $0.25 | +6,616.71% | 3 | Mar 9, 2023 | |
| ATAI Atai Life Sciences | Initiates: Buy | $18 | $1.20 | +1,400.00% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $17.17 | -0.99% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $4.05 | +739.51% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $86.95 | +9.26% | 2 | Nov 1, 2022 | |
| SAGE Sage Therapeutics | Initiates: Hold | $41 | $5.44 | +653.68% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $0.92 | +116.73% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $33 | $0.51 | +6,331.49% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $2.90 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $4.79 | +568.06% | 4 | Dec 16, 2020 |
Bionomics
Mar 9, 2023
Maintains: Buy
Price Target: $10 → $17
Current: $0.25
Upside: +6,616.71%
Atai Life Sciences
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $1.20
Upside: +1,400.00%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $17.17
Upside: -0.99%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $4.05
Upside: +739.51%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $86.95
Upside: +9.26%
Sage Therapeutics
Nov 1, 2022
Initiates: Hold
Price Target: $41
Current: $5.44
Upside: +653.68%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $0.92
Upside: +116.73%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $33
Current: $0.51
Upside: +6,331.49%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $2.90
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $4.79
Upside: +568.06%